Dr. Reddy's Labs starts manufacturing Prurisol, Cellceutix's new drug candidate Cellceutix (CTIX) wishes to update shareholders that Dr. Reddy's Laboratories (RDY) has already started on the project of manufacturing Prurisol, Cellceutix's new drug candidate for the treatment of psoriasis. As previously disclosed, the Company is advancing Prurisol directly into Phase II clinical trials under guidance from the U.S. FDA. The clinical trials are planned to commence upon the manufacturing of the drug candidate in oral form by Dr. Reddy's Laboratories.
News For CTIX;RDY From The Last 14 Days
Check below for free stories on CTIX;RDY the last two weeks.
Subscribe for More Information